10.1038/cddis.2017.28 Summary Keywords GLP-1, oral delivery, vagal afferents, diabetes, obesity, peptide Citation New RRC, Bogus M, Travers GN, Hahn U, Vaiceliunaite A, Burnet M, Wang JH and Wen H (2024) Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
While on treatment, you can still feel sick, vomit, have stomach issues, constipation and diarrhea
J., Singh, R., & White, K
Heddle, R., Fone, D., Dent, J
This condition affects the peripheral nerves, which may cause numbness, tingling, burning sensations, or difficulty with coordination and balance
The Depo-Provera Lawsuit involves claims against Pfizer, the manufacturer of the Depo-Provera contraceptive injection, for allegedly failing to warn users of serious health risks, including the potential development of brain tumors